ATPC vs NUS

For growth investors, Agape ATP Corporation (ATPC) is the stronger pick with -7.

6% revenue growth year-over-year, versus -14. 3% for Nu Skin Enterprises, Inc. (NUS). Nu Skin Enterprises, Inc. (NUS) offers the better valuation at 2. 2x trailing P/E (7. 0x forward), making it the more compelling value choice. Analysts rate Nu Skin Enterprises, Inc. (NUS) a "Hold" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Nu Skin Enterprises, Inc.

(NUS) delivered a total return of -80. 0%, compared to -100. 0% for Agape ATP Corporation (ATPC). Over 10 years, the gap is even starker: NUS returned -48. 8% versus ATPC's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Agape ATP Corporation (ATPC) is the lower-risk stock at -2.

01β versus Nu Skin Enterprises, Inc. 's 1. 49β — meaning NUS is approximately -174% more volatile than ATPC relative to the S&P 500. On balance sheet safety, Agape ATP Corporation (ATPC) carries a lower debt/equity ratio of 19% versus 45% for Nu Skin Enterprises, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Agape ATP Corporation (ATPC) is pulling ahead at -7.

6% versus -14. 3% for Nu Skin Enterprises, Inc. (NUS). On earnings-per-share growth, the picture is similar: Nu Skin Enterprises, Inc. grew EPS 207. 8% year-over-year, compared to -21. 7% for Agape ATP Corporation. Over a 3-year CAGR, ATPC leads at 9. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Nu Skin Enterprises, Inc.

(NUS) is the more profitable company, earning 10. 8% net margin versus -186. 8% for Agape ATP Corporation — meaning it keeps 10. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NUS leads at 6. 1% versus -194. 5% for ATPC. At the gross margin level — before operating expenses — NUS leads at 69. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

In this comparison, NUS (3.

4% yield) pays a dividend. ATPC does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Agape ATP Corporation (ATPC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -2.

01)). Both have compounded well over 10 years (ATPC: -100. 0%, NUS: -48. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Consumer Defensive sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: ATPC is a small-cap quality compounder stock; NUS is a small-cap deep-value stock. NUS pays a dividend while ATPC does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.